Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hip Osteoarthritis Pain Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hip Osteoarthritis Pain Drugmarket, defines the market attractiveness level of Hip Osteoarthritis Pain Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hip Osteoarthritis Pain Drug industry, describes the types of Hip Osteoarthritis Pain Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hip Osteoarthritis Pain Drug market and the development prospects and opportunities of Hip Osteoarthritis Pain Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hip Osteoarthritis Pain Drug market in Chapter 13.
By Player:
Novartis
Bayer
Astellas Pharma
GlaxoSmithKline
Abiogen Pharma
Iroko Pharmaceuticals
Almatica Pharma
Tide Pharmaceutical
Johnson & Johnson
Abbott
Daiichi Sankyo
Hengrui Pharmaceutical
Mylan
Horizon Pharma
Sanofi
Pfizer
Eli Lilly
TEVA
By Type:
Oral
Injection
External
By End-User:
Medical Care
Personal Care
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hip Osteoarthritis Pain Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hip Osteoarthritis Pain Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hip Osteoarthritis Pain Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hip Osteoarthritis Pain Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hip Osteoarthritis Pain Drug Market Analysis and Outlook to 2022
-
7.1 Global Hip Osteoarthritis Pain Drug Consumption (2017-2022)
-
7.2 United States Hip Osteoarthritis Pain Drug Consumption (2017-2022)
-
7.3 Europe Hip Osteoarthritis Pain Drug Consumption (2017-2022)
-
7.4 China Hip Osteoarthritis Pain Drug Consumption (2017-2022)
-
7.5 Japan Hip Osteoarthritis Pain Drug Consumption (2017-2022)
-
7.6 India Hip Osteoarthritis Pain Drug Consumption (2017-2022)
-
7.7 South Korea Hip Osteoarthritis Pain Drug Consumption (2017-2022)
8 Region and Country-wise Hip Osteoarthritis Pain Drug Market Analysis and Outlook to 2028
-
8.1 Global Hip Osteoarthritis Pain Drug Consumption Forecast (2022-2028)
-
8.2 United States Hip Osteoarthritis Pain Drug Consumption Forecast (2022-2028)
-
8.3 Europe Hip Osteoarthritis Pain Drug Consumption Forecast (2022-2028)
-
8.4 China Hip Osteoarthritis Pain Drug Consumption Forecast (2022-2028)
-
8.5 Japan Hip Osteoarthritis Pain Drug Consumption Forecast (2022-2028)
-
8.6 India Hip Osteoarthritis Pain Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Hip Osteoarthritis Pain Drug Consumption Forecast (2022-2028)
9 Global Hip Osteoarthritis Pain Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Hip Osteoarthritis Pain Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.3 Global External Consumption and Growth Rate (2017-2022)
-
9.2 Global Hip Osteoarthritis Pain Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Medical Care Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Personal Care Consumption and Growth Rate (2017-2022)
10 Global Hip Osteoarthritis Pain Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Hip Osteoarthritis Pain Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global External Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hip Osteoarthritis Pain Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Personal Care Consumption Forecast and Growth Rate (2022-2028)
11 Global Hip Osteoarthritis Pain Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hip Osteoarthritis Pain Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hip Osteoarthritis Pain Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hip Osteoarthritis Pain Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hip Osteoarthritis Pain Drug Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Hip Osteoarthritis Pain Drug Product and Service
-
14.2 Bayer
-
14.2.1 Bayer Company Details
-
14.2.2 Bayer Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer Hip Osteoarthritis Pain Drug Product and Service
-
14.3 Astellas Pharma
-
14.3.1 Astellas Pharma Company Details
-
14.3.2 Astellas Pharma Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Astellas Pharma Hip Osteoarthritis Pain Drug Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Hip Osteoarthritis Pain Drug Product and Service
-
14.5 Abiogen Pharma
-
14.5.1 Abiogen Pharma Company Details
-
14.5.2 Abiogen Pharma Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Abiogen Pharma Hip Osteoarthritis Pain Drug Product and Service
-
14.6 Iroko Pharmaceuticals
-
14.6.1 Iroko Pharmaceuticals Company Details
-
14.6.2 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product and Service
-
14.7 Almatica Pharma
-
14.7.1 Almatica Pharma Company Details
-
14.7.2 Almatica Pharma Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Almatica Pharma Hip Osteoarthritis Pain Drug Product and Service
-
14.8 Tide Pharmaceutical
-
14.8.1 Tide Pharmaceutical Company Details
-
14.8.2 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product and Service
-
14.9 Johnson & Johnson
-
14.9.1 Johnson & Johnson Company Details
-
14.9.2 Johnson & Johnson Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Johnson & Johnson Hip Osteoarthritis Pain Drug Product and Service
-
14.10 Abbott
-
14.10.1 Abbott Company Details
-
14.10.2 Abbott Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Abbott Hip Osteoarthritis Pain Drug Product and Service
-
14.11 Daiichi Sankyo
-
14.11.1 Daiichi Sankyo Company Details
-
14.11.2 Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Drug Product and Service
-
14.12 Hengrui Pharmaceutical
-
14.12.1 Hengrui Pharmaceutical Company Details
-
14.12.2 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product and Service
-
14.13 Mylan
-
14.13.1 Mylan Company Details
-
14.13.2 Mylan Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Mylan Hip Osteoarthritis Pain Drug Product and Service
-
14.14 Horizon Pharma
-
14.14.1 Horizon Pharma Company Details
-
14.14.2 Horizon Pharma Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Horizon Pharma Hip Osteoarthritis Pain Drug Product and Service
-
14.15 Sanofi
-
14.15.1 Sanofi Company Details
-
14.15.2 Sanofi Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Sanofi Hip Osteoarthritis Pain Drug Product and Service
-
14.16 Pfizer
-
14.16.1 Pfizer Company Details
-
14.16.2 Pfizer Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Pfizer Hip Osteoarthritis Pain Drug Product and Service
-
14.17 Eli Lilly
-
14.17.1 Eli Lilly Company Details
-
14.17.2 Eli Lilly Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Eli Lilly Hip Osteoarthritis Pain Drug Product and Service
-
14.18 TEVA
-
14.18.1 TEVA Company Details
-
14.18.2 TEVA Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 TEVA Hip Osteoarthritis Pain Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hip Osteoarthritis Pain Drug
-
Figure Hip Osteoarthritis Pain Drug Picture
-
Table Global Hip Osteoarthritis Pain Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hip Osteoarthritis Pain Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hip Osteoarthritis Pain Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hip Osteoarthritis Pain Drug Consumption by Country (2017-2022)
-
Figure United States Hip Osteoarthritis Pain Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Hip Osteoarthritis Pain Drug Consumption and Growth Rate (2017-2022)
-
Figure China Hip Osteoarthritis Pain Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Hip Osteoarthritis Pain Drug Consumption and Growth Rate (2017-2022)
-
Figure India Hip Osteoarthritis Pain Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hip Osteoarthritis Pain Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Hip Osteoarthritis Pain Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Hip Osteoarthritis Pain Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hip Osteoarthritis Pain Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hip Osteoarthritis Pain Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hip Osteoarthritis Pain Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hip Osteoarthritis Pain Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hip Osteoarthritis Pain Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global External Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Care Consumption and Growth Rate (2017-2022)
-
Figure Global Personal Care Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global External Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Personal Care Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hip Osteoarthritis Pain Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hip Osteoarthritis Pain Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Hip Osteoarthritis Pain Drug Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Hip Osteoarthritis Pain Drug Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Hip Osteoarthritis Pain Drug Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Hip Osteoarthritis Pain Drug Product and Service
-
Table Abiogen Pharma (Foundation Year, Company Profile and etc.)
-
Table Abiogen Pharma Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abiogen Pharma Hip Osteoarthritis Pain Drug Product and Service
-
Table Iroko Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product and Service
-
Table Almatica Pharma (Foundation Year, Company Profile and etc.)
-
Table Almatica Pharma Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Almatica Pharma Hip Osteoarthritis Pain Drug Product and Service
-
Table Tide Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Hip Osteoarthritis Pain Drug Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Hip Osteoarthritis Pain Drug Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Hip Osteoarthritis Pain Drug Product and Service
-
Table Hengrui Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Hip Osteoarthritis Pain Drug Product and Service
-
Table Horizon Pharma (Foundation Year, Company Profile and etc.)
-
Table Horizon Pharma Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Pharma Hip Osteoarthritis Pain Drug Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Hip Osteoarthritis Pain Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Hip Osteoarthritis Pain Drug Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Hip Osteoarthritis Pain Drug Product and Service
-
Table TEVA (Foundation Year, Company Profile and etc.)
-
Table TEVA Hip Osteoarthritis Pain Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table TEVA Hip Osteoarthritis Pain Drug Product and Service
-
